BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: O'Brien MJ, Beijerink NJ, Wade CM. Genetics of canine myxomatous mitral valve disease. Anim Genet 2021;52:409-21. [PMID: 34028063 DOI: 10.1111/age.13082] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Delwarde C, Capoulade R, Mérot J, Le Scouarnec S, Bouatia-Naji N, Yu M, Huttin O, Selton-Suty C, Sellal JM, Piriou N, Schott JJ, Dina C, Le Tourneau T. Genetics and pathophysiology of mitral valve prolapse. Front Cardiovasc Med 2023;10:1077788. [PMID: 36873395 DOI: 10.3389/fcvm.2023.1077788] [Reference Citation Analysis]
2 Ghilardi S, Lecchi C, Bagardi M, Romito G, Colombo FM, Polli M, Franco C, Brambilla PG. Prospective pilot study on the predictive significance of plasma miR-30b-5p through the study of echocardiographic modifications in Cavalier King Charles Spaniels affected by different stages of myxomatous mitral valve disease: The PRIME study. PLoS One 2022;17:e0274724. [PMID: 36574372 DOI: 10.1371/journal.pone.0274724] [Reference Citation Analysis]
3 Ghilardi S, Lecchi C, Bagardi M, Romito G, Colombo FM, Polli M, Franco C, Brambilla PG. Preliminary prospective study on the predictive significance of plasma miR-30b-5p through the study of echocardiographic modifications in Cavalier King Charles Spaniels affected by different stages of myxomatous mitral valve disease: the PRIME study.. [DOI: 10.1101/2022.09.05.506710] [Reference Citation Analysis]